Topics:

COPD

COPD

SearchMedica News
Insights from a recent search on SearchMedica
 

A new study shows that the risk of chronic obstructive pulmonary disease increases with obesity. Yet, the risk was increased in underweight persons as well.

While high-dose opioids may be deadly, lower doses may be safe for symptom reduction in severe respiratory disease. For those with milder COPD, a new treatment is in testing.

High doses of N-acetylcysteine improve small airway function in patients with COPD. The unresolved question is why.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Pages

Subscribe to COPD on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.